Inventor

WHEELER LARRY A

US73 patents

⚠️ This page may combine multiple inventors who share the name “WHEELER LARRY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WHEELER LARRY A

ALLERGAN INC

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Injectable therapy for control of muscle spasms and pain related to muscle spasms

Imidiazoles having reduced side effects

Methods and compositions for modulating alpha adrenergic receptor activity

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) Quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury

Use of platelet derived growth factor in ophthalmic wound healing

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Treating pain using selective antagonists of persistent sodium current

Treating neurological disorders using selective antagonists of persistent sodium current

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists

Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury

4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists

Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents

2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Method for using pharmaceutical compositions containing 2-(2-alkyphenyl-amino)-thiazolines as adrenergic agents

Treating pain using selective antagonists of persistent sodium current

Treating neurological disorders using selective antagonists of persistent sodium current

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds

Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract

Sustained release intraocular implants and methods for treating ocular vasculopathies

4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists

4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonists

ALLERGAN SALES INC

Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury

Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury

Methods of treating pain and other conditions

Methods and compositions for modulating alpha adrenergic receptor activity

HUANG GLENN T

Sustained release intraocular implants and methods for preventing retinal dysfunction

Sustained release intraocular implants and methods for preventing retinal dysfunction

Sustained release intraocular implants and methods for treating ocular vasculopathies

Sustained release intraocular implants and methods for treating ocular vasculopathies

UNIV JOHNS HOPKINS MED

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists

BURKE JAMES A

Intraocular implants and methods for improving vision

ALLERGAN PHARMA

Ophthalmic compositions

CHOW KEN

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds

UNIV JOHNS HOPKINS

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists